Politics Novo Nordisk bets on Wegovy pill to win weight loss battle beyond U.S. Finance News May 18, 2026 Wegovy semaglutide tablets.Michael Siluk | Universal Images Group | Getty ImagesNovo Nordisk has told CNBC how it is… Read More...
Politics Bristol Myers Squibb turns to China’s Hengrui to replenish pipeline Finance News May 15, 2026 One of America's largest pharmaceutical companies this week said it will partner with a Chinese drugmaker to test… Read More...
Politics AstraZeneca stock falls after FDA panel votes against new cancer drug Finance News May 1, 2026 Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental… Read More...
Politics Reality of Trump’s drug pricing to set in over next 18 months Finance News Apr 28, 2026 Novartis' CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a "very difficult… Read More...
Politics European pharma jeopardized by Trump policies, China’s biotech boom Finance News Apr 10, 2026 Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September… Read More...
Politics Novartis shells out $2 billion for immunology biotech Excellergy Finance News Mar 27, 2026 A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern… Read More...
Politics AstraZeneca stock jumps 4% after surprise lung disease trial win Finance News Mar 27, 2026 AstraZeneca's stock jumped as much as 4% after Britain's most valuable company said its experimental lung disease… Read More...
Politics These 4 charts show the scale of Novo Nordisk’s woes Finance News Feb 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But… Read More...
Business More drugs should be over-the-counter Finance News Feb 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes "everything should be over the… Read More...
Politics Prices, pipelines and patent cliffs: Inside pharma’s big reset Finance News Feb 13, 2026 This earnings season, Europe's biggest pharma companies posted results ranging from 7% beats to 3% misses — but no… Read More...